BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 28883003)

  • 21. Canine CD20 gene.
    Kano R; Inoiue C; Okano H; Yamazaki J; Takahashi T; Watari T; Tokuriki M; Hasegawa A
    Vet Immunol Immunopathol; 2005 Dec; 108(3-4):265-8. PubMed ID: 16061290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human transcription factor and protein kinase gene fusions in human cancer.
    Salokas K; Weldatsadik RG; Varjosalo M
    Sci Rep; 2020 Aug; 10(1):14169. PubMed ID: 32843691
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the prognostic significance of BCL6 gene expression in canine high-grade B-cell lymphoma.
    Sato M; Kanemoto H; Kagawa Y; Kobayashi T; Goto-Koshino Y; Mochizuki H; Takahashi M; Fujino Y; Ohno K; Tsujimoto H
    Vet J; 2012 Jan; 191(1):108-14. PubMed ID: 21277811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel COL1A1 exon 14/PDGFB fusion gene in dermatofibrosarcoma protuberans.
    Muchemwa FC; Jinnin M; Wakasugi S; Sakamoto M; Inoue Y; Ishihara T; Ihn H
    Eur J Dermatol; 2010; 20(3):390-1. PubMed ID: 20133221
    [No Abstract]   [Full Text] [Related]  

  • 25. The distribution of BRAF gene fusions in solid tumors and response to targeted therapy.
    Ross JS; Wang K; Chmielecki J; Gay L; Johnson A; Chudnovsky J; Yelensky R; Lipson D; Ali SM; Elvin JA; Vergilio JA; Roels S; Miller VA; Nakamura BN; Gray A; Wong MK; Stephens PJ
    Int J Cancer; 2016 Feb; 138(4):881-90. PubMed ID: 26314551
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The landscape and therapeutic relevance of cancer-associated transcript fusions.
    Yoshihara K; Wang Q; Torres-Garcia W; Zheng S; Vegesna R; Kim H; Verhaak RG
    Oncogene; 2015 Sep; 34(37):4845-54. PubMed ID: 25500544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Analysis of gene mutations in four cases of dermatofibrosarcoma protuberans.
    Saeki H; Tamada Y; Watanabe D; Akita Y; Matsumoto Y; Imai C; Kadono T; Maekawa T; Hattori N; Watanabe A; Torii H; Tamaki K
    Clin Exp Dermatol; 2006 May; 31(3):441-4. PubMed ID: 16681596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene mutation analysis in five cases of dermatofibrosarcoma protuberans using formalin-fixed, paraffin-embedded tissues.
    Saeki H; Tsunemi Y; Ohtsuki M; Kikuchi K; Tamaki K
    Acta Derm Venereol; 2005; 85(3):221-4. PubMed ID: 16040406
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A Systematic Analysis of Oncogenic Gene Fusions in Primary Colon Cancer.
    Kloosterman WP; Coebergh van den Braak RRJ; Pieterse M; van Roosmalen MJ; Sieuwerts AM; Stangl C; Brunekreef R; Lalmahomed ZS; Ooft S; van Galen A; Smid M; Lefebvre A; Zwartkruis F; Martens JWM; Foekens JA; Biermann K; Koudijs MJ; Ijzermans JNM; Voest EE
    Cancer Res; 2017 Jul; 77(14):3814-3822. PubMed ID: 28512242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Next generation sequencing approach for detecting 491 fusion genes from human cancer.
    Urakami K; Shimoda Y; Ohshima K; Nagashima T; Serizawa M; Tanabe T; Saito J; Usui T; Watanabe Y; Naruoka A; Ohnami S; Ohnami S; Mochizuki T; Kusuhara M; Yamaguchi K
    Biomed Res; 2016; 37(1):51-62. PubMed ID: 26912140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic efficacy of the human B-cell lymphoma prognostic genes in predicting disease-free survival (DFS) in the canine counterpart.
    Zamani-Ahmadmahmudi M; Aghasharif S; Ilbeigi K
    BMC Vet Res; 2017 Jan; 13(1):17. PubMed ID: 28069005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of tyrosine-kinase receptor c-kit mutations, mRNA and protein expression in canine lymphoma: might c-kit represent a therapeutic target?
    Giantin M; Aresu L; Aricò A; Gelain ME; Riondato F; Comazzi S; Dacasto M
    Vet Immunol Immunopathol; 2013 Aug; 154(3-4):153-9. PubMed ID: 23791075
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of COL1A1-PDGFB fusion transcripts in superficial adult fibrosarcoma suggests a close relationship to dermatofibrosarcoma protuberans.
    Sheng WQ; Hashimoto H; Okamoto S; Ishida T; Meis-Kindblom JM; Kindblom LG; Hisaoka M
    J Pathol; 2001 May; 194(1):88-94. PubMed ID: 11329146
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of hepatocyte growth factor and the proto-oncogenic receptor c-Met in canine osteosarcoma.
    Fieten H; Spee B; Ijzer J; Kik MJ; Penning LC; Kirpensteijn J
    Vet Pathol; 2009 Sep; 46(5):869-77. PubMed ID: 19429984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative aspects of microRNA expression in canine and human cancers.
    Sahabi K; Selvarajah GT; Abdullah R; Cheah YK; Tan GC
    J Vet Sci; 2018 Mar; 19(2):162-171. PubMed ID: 28927253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma.
    Ueda C; Akasaka T; Kurata M; Maesako Y; Nishikori M; Ichinohasama R; Imada K; Uchiyama T; Ohno H
    Oncogene; 2002 Jan; 21(3):368-76. PubMed ID: 11821949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5'-RACE and LA - PCR analyses of biopsy samples.
    Yoshida S; Kaneita Y; Aoki Y; Seto M; Mori S; Moriyama M
    Oncogene; 1999 Dec; 18(56):7994-9. PubMed ID: 10637510
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [From cytogenetics to cytogenomics of dermatofibrosarcoma protuberans family of tumors].
    Bianchini L; Maire G; Pedeutour F;
    Bull Cancer; 2007 Feb; 94(2):179-89. PubMed ID: 17337387
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Identification of t(17;22)(q22;q13) (COL1A1/PDGFB) in dermatofibrosarcoma protuberans by fluorescence in situ hybridization in paraffin-embedded tissue microarrays.
    Segura S; Salgado R; Toll A; Martín-Ezquerra G; Yébenes M; Sáez A; Solé F; Barranco C; Umbert P; Espinet B; Pujol RM
    Hum Pathol; 2011 Feb; 42(2):176-84. PubMed ID: 21111450
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages.
    Mariño-Enríquez A; Dal Cin P
    Cancer Genet; 2013 Nov; 206(11):357-73. PubMed ID: 24091028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.